Division of Perioperative Care and Emergency Medicine, Department of Anaesthesiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Br J Anaesth. 2010 Aug;105(2):122-30. doi: 10.1093/bja/aeq111. Epub 2010 Jun 23.
In experimental and clinical studies, volatile anaesthesia has proven to possess cardioprotective properties. However, no randomized controlled trials on the use of isoflurane during the entire cardiac surgical procedure are available. We therefore compared isoflurane-sufentanil vs propofol-sufentanil anaesthesia in patients undergoing coronary artery bypass grafting.
One hundred patients were randomly assigned to receive isoflurane-sufentanil (I) (n = 51) or propofol-sufentanil (P) (n = 49) anaesthesia, aimed at the same hypnotic depth. Postoperative concentrations of cardiac troponin I (cTnI) were followed for 72 h. Secondary outcome variables were length of stay (LOS) in the intensive care unit (ICU) and in hospital, and 30 day and 1 yr mortality and morbidity, defined as acute myocardial infarction, arrhythmias, and cardiac dysfunction. Groups were compared by an on-treatment analysis, using linear mixed models for repeated measures.
Eighty-four patients completed the protocol (I: 41 vs P: 43). Postoperative cTnI concentrations increased to a maximum of I: 2.72 ng ml(-1) (1.78-5.85) and P: 2.64 ng ml(-1) (1.67-4.83), but did not differ between groups (P=0.11). LOS in the ICU and in hospital was similar [ICU I: 18 (17.0-21.5) vs P: 19 (17.0-22.0) h; hospital I: 9 (6.5-8.0) vs P: 8 (6.0-9.0) days]. Cardiac morbidity and mortality in hospital and 30 days after surgery did not differ between groups. One year after surgery, two patients had died of non-cardiac causes. No between-group differences in cardiac morbidity were found.
In this study, the use of isoflurane-sufentanil in comparison with propofol-sufentanil anaesthesia does not afford additional reduction of postoperative cTnI levels.
在实验和临床研究中,挥发性麻醉已被证明具有心脏保护作用。然而,目前尚无关于在整个心脏外科手术过程中使用异氟醚的随机对照试验。因此,我们比较了在接受冠状动脉旁路移植术的患者中使用异氟醚-舒芬太尼与异丙酚-舒芬太尼麻醉。
100 名患者被随机分为接受异氟醚-舒芬太尼(I)(n = 51)或异丙酚-舒芬太尼(P)(n = 49)麻醉的两组,两组的麻醉深度目标相同。术后 72 小时内监测心肌肌钙蛋白 I(cTnI)的浓度。次要结局变量为重症监护病房(ICU)和住院时间(LOS)以及 30 天和 1 年死亡率和发病率,定义为急性心肌梗死、心律失常和心功能障碍。通过治疗分析比较两组,采用重复测量线性混合模型。
84 名患者完成了方案(I:41 名 vs P:43 名)。术后 cTnI 浓度升高至最大值:I:2.72ng/ml(1.78-5.85)和 P:2.64ng/ml(1.67-4.83),但两组之间无差异(P=0.11)。ICU 和住院 LOS 相似[ICU I:18(17.0-21.5)vs P:19(17.0-22.0)h;医院 I:9(6.5-8.0)vs P:8(6.0-9.0)天]。术后住院期间和 30 天的心脏发病率和死亡率在两组之间无差异。术后 1 年,有 2 名患者因非心脏原因死亡。两组之间在心脏发病率方面没有差异。
在这项研究中,与异丙酚-舒芬太尼麻醉相比,使用异氟醚-舒芬太尼麻醉并不能进一步降低术后 cTnI 水平。